Alzheimer’s disease(AD) is the most common form of dementia. In the past few decades, great advances have been made in the understanding of its pathophysiology due to the use of biomarkers. Imaging biomarkers, either based on structural brain changes and metabolic alterations alone, or in conjunction with cerebrospinal fluid(CSF) biomarkers, can be informative of the ongoing pathological processes occurring in a patient with AD. In our method, we propose a novel MRI biomarker that is based on the extraction of structural features from a T1-w MRI scan, and it provides biological characterization of early and later forms of AD.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords